Skip to main content
. Author manuscript; available in PMC: 2016 Apr 25.
Published in final edited form as: Eur J Cancer. 2016 Feb 12;56:162–171. doi: 10.1016/j.ejca.2015.12.022

Table 1.

Clinical characteristics of a patient with newly diagnosed advanced NSCLC best suited for nab-PC.

1. Squamous cell histology
2. High burden of disease-related symptoms, which might be relieved by tumour response
3. Pre-existing neuropathy or at risk for the development of neuropathy
4. Elderly
5. Pre-existing diabetes or prediabetic state
6. Comorbid mild or moderate renal dysfunction

nab-PC, nab-paclitaxel/carboplatin; NSCLC, non-small cell lung cancer.